6 results

  • eligard

    (Leuprolide Acetate)
    TOLMAR Inc.
    ELIGARD® is indicated for the palliative treatment of advanced prostate cancer.

  • fensolvi

    (Leuprolide Acetate)
    TOLMAR Inc.
    FENSOLVI® is indicated for treating central precocious puberty (CPP) in pediatric patients aged 2 years and older.

  • lupron depot

    (leuprolide acetate)
    AbbVie Inc.
    LUPRON DEPOT 11.25 mg is indicated for managing endometriosis, including pain relief and lesion reduction, as well as for preoperative anemia improvement in women with uterine leiomyomata (fibroids), used with iron therapy. It is not meant for prolonged use or specific combinations beyond stated limits.

  • supprelin

    (histrelin acetate)
    ENDO USA, Inc.
    SUPPRELIN LA (histrelin acetate) is indicated for treating children with central precocious puberty (CPP), characterized by early sexual development before age 8 in females and 9 in males, and advanced bone age. Diagnosis should be confirmed through hormonal assessments and imaging to rule out underlying conditions.

  • trelstar

    (triptorelin pamoate)
    Verity Pharmaceuticals Inc.
    TRELSTAR is indicated for the treatment of advanced prostate cancer.

  • zoladex

    (goserelin)
    TerSera Therapeutics LLC
    ZOLADEX is indicated for the management of locally confined Stage B2-C prostatic carcinoma (with flutamide), palliative treatment of advanced prostatic carcinoma, management of endometriosis, endometrial thinning prior to ablation, and palliative treatment of advanced breast cancer in pre- and perimenopausal women.